{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:23:48Z","timestamp":1792167828329,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejso.2023.04.015","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T20:09:38Z","timestamp":1682194178000},"page":"106916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["How to handle brain tumors after esophagectomy with curative intent: A single center 20-year experience"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8432-1685","authenticated-orcid":false,"given":"Stijn","family":"Vanstraelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8230-5649","authenticated-orcid":false,"given":"Lieven","family":"Depypere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-3102","authenticated-orcid":false,"given":"Johnny","family":"Moons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Mandeville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1153-8298","authenticated-orcid":false,"given":"Hans","family":"Van Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8965-4283","authenticated-orcid":false,"given":"Toni","family":"Lerut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy","family":"Coosemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Nafteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2023.04.015_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4251\/wjgo.v6.i5.112","article-title":"Esophageal cancer: a Review of epidemiology, pathogenesis, staging workup and treatment modalities","volume":"6","author":"Napier","year":"2014","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib2","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/01.JTO.0000437420.38972.fb","article-title":"Esophageal cancer recurrence patterns and implications for surveillance","volume":"8","author":"Lou","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib4","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib5","first-page":"1","article-title":"Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road","volume":"30","author":"Depypere","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ejso.2023.04.015_bib6","first-page":"1","article-title":"Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study","volume":"32","author":"Seesing","year":"2019","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"},{"key":"10.1016\/j.ejso.2023.04.015_bib7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.21037\/jgo.2016.03.12","article-title":"Outcomes in patients with brain metastasis from esophageal carcinoma","volume":"7","author":"Kothari","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib8","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/cncr.11737","article-title":"Metastasis of esophageal carcinoma to the brain","volume":"98","author":"Weinberg","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2023.04.015_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00947","article-title":"Current trends for improving safety of stereotactic brain biopsies: advanced optical methods for vessel avoidance and tumor detection","volume":"9","author":"Akshulakov","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2022.822362","article-title":"Diagnostic yield and complication rate of stereotactic biopsies in precision medicine of gliomas","volume":"13","author":"Katzendobler","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.ejso.2023.04.015_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2214\/AJR.10.4752","article-title":"Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions","volume":"196","author":"Lee","year":"2011","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ejso.2023.04.015_bib12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/brb3.288","article-title":"Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging","volume":"4","author":"Ding","year":"2014","journal-title":"Brain Behav"},{"key":"10.1016\/j.ejso.2023.04.015_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00234-004-1246-7","article-title":"Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings","volume":"46","author":"Chiang","year":"2004","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ejso.2023.04.015_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejrad.2019.01.008","article-title":"Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging","volume":"112","author":"Xi","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejso.2023.04.015_bib15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s10120-020-01075-3","article-title":"Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases","volume":"23","author":"Harada","year":"2020","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2023.04.015_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.athoracsur.2019.09.028","article-title":"Incidence and risk factors for isolated esophageal cancer recurrence to the brain","volume":"109","author":"Nobel","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejso.2023.04.015_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2006.06.089","article-title":"Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?","volume":"82","author":"Rice","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejso.2023.04.015_bib18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1470-2045(02)00819-7","article-title":"Metastasis to and from the central nervous system - the \u201crelatively protected site","volume":"3","author":"Subramanian","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000354736","article-title":"Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance","volume":"85","author":"Wadhwa","year":"2013","journal-title":"Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/SLA.0000000000002670","article-title":"Multi-institutional analysis of recurrence and survival after neoadjuvant chemoradiotherapy of esophageal cancer: impact of histology on recurrence patterns and outcomes","volume":"269","author":"Xi","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.04.015_bib21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jtcvs.2018.09.136","article-title":"Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgery","volume":"157","author":"Barbetta","year":"2019","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejso.2023.04.015_bib22","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1245\/s10434-015-4619-8","article-title":"Predictive factors of recurrence in patients with pathological complete response after esophagectomy following neoadjuvant chemoradiotherapy for esophageal cancer: a multicenter study","volume":"22","author":"Luc","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/cncr.10271","article-title":"Brain metastases from esophageal carcinoma: natural history, prognostic factors, and outcome","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2023.04.015_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-08918-x","article-title":"Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy","volume":"21","author":"Nagaki","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2023.04.015_bib25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jtcvs.2009.07.069","article-title":"Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response?","volume":"138","author":"Meguid","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejso.2023.04.015_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrc2587","article-title":"Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype","volume":"9","author":"Barnett","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejso.2023.04.015_bib27","article-title":"Effects of radiation on endothelial barrier and vascular integrity","author":"Bouten","year":"2021","journal-title":"Elsevier"},{"key":"10.1016\/j.ejso.2023.04.015_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00000658-194007000-00016","article-title":"The function of the vertebral veins and their role in the spread of Metasteses.pdf","volume":"112","author":"Batson","year":"1940","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.04.015_bib29","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1002\/cncr.30953","article-title":"Pathological complete response in patients with esophageal cancer after the trimodality approach: the association with baseline variables and survival\u2014the University of Texas MD Anderson Cancer Center experience","volume":"123","author":"Blum Murphy","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2023.04.015_bib30","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/bjc.2011.175","article-title":"Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma","volume":"104","author":"Fields","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2023.04.015_bib31","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1158\/1541-7786.MCR-11-0534","article-title":"Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells","volume":"10","author":"Ridgway","year":"2012","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ejso.2023.04.015_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7716","article-title":"Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier","volume":"6","author":"Tominaga","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejso.2023.04.015_bib33","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41556-019-0404-4","article-title":"Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis","volume":"21","author":"Rodrigues","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ejso.2023.04.015_bib34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/0973-1482.154024","article-title":"Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung","volume":"12","author":"Shin","year":"2016","journal-title":"J\u00a0Cancer Res Therapeut"},{"key":"10.1016\/j.ejso.2023.04.015_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11060-022-04195-1","article-title":"Erythroblastic oncogene B-2 status and intracranial metastatic disease in patients with gastrointestinal cancer: a systematic review","volume":"160","author":"Sherman","year":"2022","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-017-0919-0","article-title":"Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review","volume":"34","author":"Ghidini","year":"2017","journal-title":"Med Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00401-011-0933-9","article-title":"Brain metastases: pathobiology and emerging targeted therapies","volume":"123","author":"Preusser","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ejso.2023.04.015_bib38","first-page":"1065","article-title":"Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies","volume":"33","author":"Preusser","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2023.04.015_bib39","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","article-title":"Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014","volume":"4","author":"Ostrom","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2023.04.015_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/neuros\/nyw166","article-title":"Quality of life following stereotactic radiosurgery for single and multiple brain metastases","volume":"81","author":"Miller","year":"2017","journal-title":"Neurosurgery"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323004754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323004754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:40:35Z","timestamp":1782884435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323004754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0748798323004754"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.04.015","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to handle brain tumors after esophagectomy with curative intent: A single center 20-year experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106916"}}